Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
- Autores
- Bouzat, Cecilia Beatriz
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapy
Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
XLVII Reunión Anual de la Sociedad Argentina de Biofísica
La Plata
Argentina
Sociedad Argentina de Biofísica - Materia
-
NICOTINIC RECEPTORS
THERAPEUTIC DRUG TARGETS
DRUG MODULATION - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/201047
Ver los metadatos del registro completo
id |
CONICETDig_f98d34f985341267f2bcfd8a9c57dad7 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/201047 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulationBouzat, Cecilia BeatrizNICOTINIC RECEPTORSTHERAPEUTIC DRUG TARGETSDRUG MODULATIONhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapyFil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaXLVII Reunión Anual de la Sociedad Argentina de BiofísicaLa PlataArgentinaSociedad Argentina de BiofísicaSociedad Argentina de BiofísicaCelej, Maria SoledadAcierno, Juan Pablo2018info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectConferenciaBookhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/201047Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation; XLVII Reunión Anual de la Sociedad Argentina de Biofísica; La Plata; Argentina; 2018; 26-26978-987-27591-6-2CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://biofisica.org.ar/reuniones-cientificas/reunionsab-previas/Nacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:05:20Zoai:ri.conicet.gov.ar:11336/201047instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:05:20.834CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation |
title |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation |
spellingShingle |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation Bouzat, Cecilia Beatriz NICOTINIC RECEPTORS THERAPEUTIC DRUG TARGETS DRUG MODULATION |
title_short |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation |
title_full |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation |
title_fullStr |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation |
title_full_unstemmed |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation |
title_sort |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation |
dc.creator.none.fl_str_mv |
Bouzat, Cecilia Beatriz |
author |
Bouzat, Cecilia Beatriz |
author_facet |
Bouzat, Cecilia Beatriz |
author_role |
author |
dc.contributor.none.fl_str_mv |
Celej, Maria Soledad Acierno, Juan Pablo |
dc.subject.none.fl_str_mv |
NICOTINIC RECEPTORS THERAPEUTIC DRUG TARGETS DRUG MODULATION |
topic |
NICOTINIC RECEPTORS THERAPEUTIC DRUG TARGETS DRUG MODULATION |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapy Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina XLVII Reunión Anual de la Sociedad Argentina de Biofísica La Plata Argentina Sociedad Argentina de Biofísica |
description |
Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapy |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Conferencia Book http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
status_str |
publishedVersion |
format |
conferenceObject |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/201047 Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation; XLVII Reunión Anual de la Sociedad Argentina de Biofísica; La Plata; Argentina; 2018; 26-26 978-987-27591-6-2 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/201047 |
identifier_str_mv |
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation; XLVII Reunión Anual de la Sociedad Argentina de Biofísica; La Plata; Argentina; 2018; 26-26 978-987-27591-6-2 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://biofisica.org.ar/reuniones-cientificas/reunionsab-previas/ |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.coverage.none.fl_str_mv |
Nacional |
dc.publisher.none.fl_str_mv |
Sociedad Argentina de Biofísica |
publisher.none.fl_str_mv |
Sociedad Argentina de Biofísica |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269906773475328 |
score |
13.13397 |